U.S. Markets open in 8 hrs 18 mins

Alexion: Analysts Raise Their Target Prices

Sarah Collins
Alexion: Analysts Raise Their Target Prices

Alexion Pharmaceuticals (ALXN) is one of the leading biotechnology firms. Soliris is approved to treat aHUS (atypical hemolytic uremic syndrome) and PHN (paroxysmal nocturnal hemoglobinuria). Alexion’s latest acquisition of Wilson Therapeutics is a turnaround strategy that’s being implemented to restructure Alexion’s performance and investors’ sentiments in the market.